This is a paid press release. Contact the press release distributor directly with any inquiries.

UTulsa’s Hurricane Ventures announces investment in BioReact

PR Newswire

Fri, February 13, 2026 at 7:52 AM GMT+9 2 min read

TULSA, Okla., Feb. 12, 2026 /PRNewswire/ – The University of Tulsa and Hurricane Ventures have announced an investment in BioReact, an artificial intelligence and analytics platform powering modern bioprocess development and optimization. The funding will be used to accelerate go-to-market efforts and expand BioReact’s product capabilities.

The University of Tulsa (PRNewsfoto/University of Tulsa)

Launched in April 2023, Hurricane Ventures invests in early-stage companies with strategic connections to the university. The fund leverages the university’s knowledge network and resources; advances UTulsa’s innovation ecosystem; and drives success across its portfolio as well as economic growth across the region.

BioReact provides a unified system where teams can bring together data from multiple sources into a structured foundation. Scientists working with bioreactors – specialized containers where cells are grown to develop medicines and vaccines – typically spend four to five hours manually organizing data from devices, spreadsheets and lab notebooks before they can analyze results.

BioReact lets scientists upload data from disparate sources and automatically align datasets, visualizing results in seconds. The platform’s AI analyzes parameters like temperature, pH and nutrient concentrations to identify optimal growth conditions that improve yields, reduce costs and shorten development cycles. The platform requires no coding expertise and has applications across industries like biopharma, industrial biotech and synthetic biology.

“The support from The University of Tulsa and Hurricane Ventures allows us to accelerate development of software that genuinely serves scientists. Beyond the capital, access to UTulsa’s exceptional biotech talent gives us a unique advantage in refining the product alongside real scientific expertise, ensuring BioReact continues to deliver meaningful, practical improvements for teams running complex bioprocesses,” said Mitchell Castetter, CEO and co-founder.

Castetter has spent more than a decade in biotech sales at Beckman Coulter and Cytena. His co-founder Joanna Lipinski, Ph.D., brings over 20 years of experience spanning high-tech and biotech, with a career focused on building advanced software and data platforms that power modern scientific research.

“We are excited to support founders Mitchell and Joanna as they modernize bioprocess development and help scientists work more efficiently,” said Chris Wright, assistant vice president and leader of UTulsa’s Center for Innovation & Entrepreneurship.

Story Continues  

BioReact is the 12th company to receive support from Hurricane Ventures.

“We’re thrilled to back this team as they modernize the bioprocess workflow and ultimately help accelerate the development of pharmaceuticals and other critical products,” said Connor Sitton, director of Hurricane Ventures.

Cision

View original content to download multimedia:

Terms and Privacy Policy

Privacy Dashboard

More Info